Scarica l'app Stockscreener
2.59
2.37%
0.06
Dopo l'orario di chiusura:
2.59
Precedente Chiudi:
$2.53
Aprire:
$2.53
Volume 24 ore:
18,907
Relative Volume:
0.87
Capitalizzazione di mercato:
$64.98M
Reddito:
$6.21M
Utile/perdita netta:
$-19.92M
Rapporto P/E:
-1.3282
EPS:
-1.95
Flusso di cassa netto:
$-16.76M
1 W Prestazione:
+5.50%
1M Prestazione:
+4.02%
6M Prestazione:
+12.61%
1 anno Prestazione:
-11.13%
Intervallo 1D:
$2.4902
$2.59
Intervallo di 1 settimana:
$2.07
$3.05
Portata 52W:
$1.81
$3.42
InspireMD Inc. Stock (NSPR) Company Profile
Nome
InspireMD Inc.
Settore
Industria
Telefono
972 3 6917691
Indirizzo
4 Menorat Hamaor Street, Tel Aviv
Confronta NSPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| NSPR | 2.59 | 64.98M | 6.21M | -19.92M | -16.76M | -1.95 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2016-01-07 | Iniziato | Rodman & Renshaw | Buy |
| 2015-03-13 | Downgrade | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Iniziato | Oppenheimer | Outperform |
InspireMD Inc. Borsa (NSPR) Ultime notizie
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
InspireMD Inc (NSPR) Quarterly 10-Q Report - Quartzy
InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023) - Yahoo Finance
InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript - Insider Monkey
InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges - TipRanks
InspireMD Inc. Reports Q3 2024 Financial Results - TipRanks
InspireMD Achieves Record Q3 Revenue with CGuard Success - TipRanks
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings - Yahoo Finance
InspireMD announces inducement grants - Medical Buyer
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - XM
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
InspireMD (NSPR) to Release Quarterly Earnings on Tuesday - MarketBeat
InspireMD to Report Third Quarter 2024 Financial Results - GlobeNewswire
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th - The Manila Times
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - MarketBeat
Rosalind Advisors, Inc. Acquires Shares in InspireMD Inc - GuruFocus.com
One InspireMD Insider Raised Stake By 13% In Previous Year - Yahoo Finance
InspireMD (NYSE:NSPR) Research Coverage Started at StockNews.com - MarketBeat
10+ things to know in #MiamiTech: News from InspireMD, 1NCE, Flow, UrbanLink, Carve Communications, Miami Dade College, Aleph, Taxfyleand lots of opportunities! - Refresh Miami
InspireMD Expands with New Miami Headquarters - TipRanks
InspireMD Announces Establishment of Global Headquarters in - GlobeNewswire
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System - StockTitan
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent - Yahoo Finance
InspireMD (NSPR) Price Target Increased by 11.49% to 4.95 - MSN
InspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.com - MarketBeat
InspireMD Advances with FDA Study Approval and Global Goals - Yahoo Finance
FDA approves InspireMD's pivotal carotid stent study - Investing.com
FDA approves InspireMD's pivotal carotid stent study By Investing.com - Investing.com Australia
InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System - The Manila Times
InspireMD Announces Approval of Investigational Device - GlobeNewswire
Recent Investment Analysts’ Ratings Updates for InspireMD (NSPR) - Defense World
InspireMD Launches New Employee Inducement Plan - Investing.com
InspireMD Launches 2024 Plan to Attract Talent with Stock - TipRanks
Nantahala Capital Management LLC Sells 39,856 Shares of InspireMD, Inc. (NYSE:NSPR) - Defense World
Samlyn Capital LLC Sells 228,380 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World
Does Insmed Inc (INSM) offer a good opportunity for investors? - SETE News
EverSource Wealth Advisors LLC Acquires 281 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
Ensign Peak Advisors Inc Trims Stake in Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Acquires 25,714 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) - MarketBeat
Does Inspire Medical Systems Inc (INSP) offer a good opportunity for investors? - SETE News
Holdings of Inspire Veterinary Partners Inc. (IVP) are aligned with the stars - SETE News
SilverBox Corp IV appoints Reed Seaton to its board - Investing.com India
Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Lessened by Integral Health Asset Management LLC - Defense World
Wolfe Research downgrades SITE Centers Corp (SITC) rating to a Peer perform - Knox Daily
Edge Capital Group LLC Has $331,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG) - Defense World
InspireMD Inc. Azioni (NSPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):